Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
13F holders, Q2 2022
Institutional positions in Sunshine Biopharma Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +5 vs. Q1 2022
- Shares held
- 737.5K
- −732.2K (−49.8%) vs. Q1 2022
- Total value
- $802.1K
- −$2.75M (−77.4%) vs. Q1 2022
- New holders
- 9
- 3 more added
- Sold out
- 4
- 1 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SBFM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $32.6K |
| Q1 2026 | 12 | $127.1K |
| Q4 2025 | 13 | $141.7K |
| Q3 2025 | 14 | $337.3K |
| Q2 2025 | 12 | $187.2K |
| Q1 2025 | 11 | $151.7K |
| Q4 2024 | 12 | $61.8K |
| Q3 2024 | 10 | $111.3K |
| Q2 2024 | 11 | $89.6K |
| Q1 2024 | 15 | $346.2K |
| Q4 2023 | 15 | $745.7K |
| Q3 2023 | 11 | $415.1K |
| Q2 2023 | 10 | $1.25M |
| Q1 2023 | 13 | $292.4K |
| Q4 2022 | 12 | $261.8K |
| Q3 2022 | 12 | $341.1K |
| Q2 2022 | 18 | $802.1K |
| Q1 2022 | 13 | $3.55M |
| Q4 2021 | 1 | $17.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Sunshine Biopharma Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bridgeway Capital Management, LLC | 568,400 | $614.0K | 0.01% | +568,400 | New |
| Virtu Financial LLC | 47,861 | $52.0K | 0.00% | +33,898+242.8% | Added |
| Bank of Montreal | 31,000 | $40.0K | 0.00% | +31,000 | New |
| Two Sigma Securities, LLC | 20,722 | $22.0K | 0.00% | +7,675+58.8% | Added |
| Dakota Wealth Management | 20,000 | $22.0K | 0.00% | +20,000 | New |
| Geode Capital Management, LLC | 20,179 | $21.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,128 | $9.00K | 0.00% | +4,043+99.0% | Added |
| Advisor Group Holdings, Inc. | 7,528 | $8.00K | 0.00% | +7,528 | New |
| Morgan Stanley | 6,867 | $7.00K | 0.00% | +6,867 | New |
| Bank of America Corp | 3,330 | $4.00K | 0.00% | +3,330 | New |
| Captrust Financial Advisors | 1,464 | $2.00K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 1,042 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 79 | $85 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $0 | 0.00% | −2,433−100.0% | Reduced |
| Signaturefd, LLC | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 130 | $0 | 0.00% | +130 | New |
| Larson Financial Group LLC | 127 | $0 | 0.00% | +127 | New |
| Rise Advisors, LLC | 293 | $0 | 0.00% | +293 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −635,002−100.0% | Sold out |
| Empery Asset Management, LP | 0 | $0 | 0.00% | −450,450−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −315,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,640−100.0% | Sold out |